Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2010

View Archived Issues

SYN-115 enhances effects of levodopa in Parkinson's disease patients

FDA approves labeling update for Tibotec's Prezista for HIV-1

IND to test androxal in men with type 2 diabetes and hypogonadism now effective

Gilead reports fourth quarter 2009 results

PROSPER data indicate no effect of pravastatin sodium on cognitive decline in the elderly

Antitumor activity of GMX-1777 plus radiotherapy seen in head and neck cancer models

Possible correlation between gender and genotype reported in pediatric onset of CD

AstraZeneca discloses novel Nav1.7 voltage-gated sodium channel blockers

Princeton University claims quorum-sensing signaling modulators for bacterial infections

Boehringer Ingelheim claims new chemokine CCR10 receptor antagonists

Labopharm receives FDA approval for Oleptro for major depressive disorder

Pharmasset describes new prodrugs of NS5B inhibitors

New antiepileptic agents described by University of North Carolina at Chapel Hill

FDA requests additional information for Protalix's taliglucerase alfa NDA

Onyx agrees with the FDA on a SPA for planned phase III carfilzomib trial

Vantia's VA-106483 enters phase IIb trial for nocturia

FDA approves Xiaflex for debilitating hand disease

Recordati receives European approval for silodosin for BPH

NeuroSearch presents topline results from phase III Huntexil study

Evotec and Vifor sign agreement to identify preclinical candidate in anemia

Spectrum and TopoTarget sign agreement for HDAC inhibitor belinostat

FDA accepts for formal review Javelin's NDA for NSAID Dyloject

EMEA issues scientific advice to Hybrigenics for clinical development of inecalcitol

Seattle and Millennium initiate phase I combination clinical trial of brentuximab

Oxytocin attenuates methamphetamine self-administration in rats

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...